All Access

Health Tech Deals

Health Tech Deals Alerts

Alert

Standard

Health Tech Deals Thought Bubble

Thought Bubble

mustard

BFD Expert Voices - Health Tech Deals

BFD Expert Voices

topics

politics-policy

epstein-files

donald-trump

2026-midterm-elections

immigration

behind-the-curtain

race-and-equity

technology

privacy-tech-regulation

automation-and-ai

tiktok-news

big-tech

social-media

cybersecurity

economy

social-security

inflation

tariffs

federal-reserve

jobs

transportation

business

stock-market-news

retail-news

crypto

media

elon-musk

dealmaking

health

rfk-jr

drug-prices

axios-explains-abortion

public-health

world

israel

axios-explains-ukraine

iran

russia

china

energy-climate

nuclear-energy

climate-energy-policy

climate-change

extreme-weather

alternative-energy

electric-vehicles

science

emerging-tech

biomedicine

newsletters

pittsburgh

atlanta

san-diego

charlotte

boulder

washington-dc

kansas-city

dallas

denver

detroit

des-moines

austin

boston

chicago

cleveland

columbus

houston

indianapolis

miami

nashville

new-orleans

nw-arkansas

philadelphia

phoenix

portland

richmond

salt-lake-city

san-antonio

san-francisco

seattle

tampa-bay

twin-cities

raleigh

huntsville

colorado-springs

axios-local

axios-pro

axios-live

the-axios-show

RISA Labs raised $11.1 million in a Series A funding co-led by Cencora Ventures and Optum Ventures, CEO Kshitij Jaggi tells Axios Pro exclusively.

Why it matters: Health care incumbents are showing interest in the AI agent craze.

Follow the money: Other participants included Oncology Ventures, Z21 Ventures and General Catalyst co-founder John Simon through his Ventureforgood investment holding company.

How it works: RISA has developed AI agents that help with health care workflows associated with cancer patients.

The company's AI agents are embedded in provider electronic health record software. Its agents can create and submit medical necessity documents to payors.

RISA has developed tools for checking patients' medical and pharmacy benefits as well as approving radiology tests and prescriptions.

Zoom in: The Palo Alto, Calif.-based company is currently working with seven practices, but plans to scale to 100 by the end of 2027.

RISA sells its AI agents to providers like cancer centers or health system oncology departments.

Catch up quick: In December, Cencora announced plans to acquire the majority of OneOncology's outstanding equity it does not own, including shares from TPG, for approximately $5 billion.

What's next: The round gives RISA two to three years of runway, but it could raise sooner than that, Jaggi says.

Exclusive: RISA Labs raises $11.1M for oncology AI agents

Health care incumbents are showing some interest in the AI agent craze.

Illustration of a light blue ribbon glowing with binary code.

RISA Labs raised $11.1 million in a Series A funding co-led by Cencora Ventures and Optum Ventures, CEO Kshitij Jaggi tells Axios Pro exclusively.Why it matters: Health care incumbents are showing interest in the <a class="gtmContentClick" data-vars-link-text="AI agent craze" data-vars-click-url="https://www.axios.com/pro/health-tech-deals/2025/11/25/ai-agents-health-care-workflow" data-vars-content-id="2dfd888c-f74c-4b50-a7ad-cd95180c5c19" data-vars-headline="Exclusive: RISA Labs raises $11.1M for oncology AI agents" data-vars-event-category="story" data-vars-sub-category="story" data-vars-item="in_content_link" href="https://www.axios.com/pro/health-tech-deals/2025/11/25/ai-agents-health-care-workflow" target="_self">AI agent craze</a>.

Exclusive: RISA Labs raises $11.1M for oncology AI agents

What to read next